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Summary 
In a recent paper: Goldstein I, Baek S, Presman DM, Paakinaho V, Swinstead EE, 
Hager GL. Transcription factor assisted loading and enhancer dynamics dictate the 
hepatic fasting response. Genome Res. 2017 Mar;27(3):427–39., the authors used a 
number of functional genomics approaches to explore the transcriptional regulatory dynamics 10 
that occur during hepatic fasting. They used chromatin landscape data to identify key fasting-
related transcription factors, four of which were further investigated because they are known 
players of the fasting response: CEBPB (CCAAT enhancer binding-beta), CREB1 (cAMP 
responsive element binding protein I), GR (glucocorticoid receptor), and PPARA 
(peroxisome proliferator activated receptor alpha). The authors described two operating 15 
modules (GR-CREB1 and PPARA-GR) with synergistic effects driving gluconeogenesis 
through an assisted loading model and fatty acid oxidation/ketogenesis through a transcription 
factor cascade, respectively. Finally, using single-cell tracking, they confirmed that GR 
facilitates CREB1 binding to DNA. 
 20 
General Background 
Upon food deprivation, the liver maintains metabolic homeostasis by first 
upregulating both glycogen mobilization and gluconeogenesis. During protracted fasting, 
glucose production shifts to fatty acid oxidation and ketogenesis. These metabolic responses 
are driven by multiple transcription factors that regulate the enzymes that catalyse key steps in 25 
the production of glucose. Regulators of the gluconeogenesis pathway include FOXO1 
(Forkhead Box Protein 1), CEBPB, and GR, although to what extent CREB1 contributes to 
regulation of the fasting metabolic response remains controversial (1,2). In contrast, PPARA 
is a master regulator of fatty acid oxidation (1). 
The regulatory dynamics of the hepatic response to fasting remain poorly understood. 30 
Where do transcription factors bind (enhancers and promoters)? How do they bind (regulation 
hierarchy and logic)? What are the genes they regulate? 
Genome-wide technologies such as chromatin immunoprecipitation (ChIP-chip, ChIP-
seq or ChIP-exo) and chromatin accessibility (Dnase-seq or ATAC-seq) can now 
quantitatively identify chromatin structure and transcription factor occupancy, and have been 35 
recently used to explore cistromes of fasting-related transcription factors in mouse liver. GR 
binding at GRE (Glucocorticoid receptor element) is associated with binding sites of other 
transcription factors like CEBPB in response to fasting (3,4). Interestingly, CEBPB was 
required for GR access and binding to DNA, leading to the model of assisted transcription 
factors loading (4). In contrast, CREB1 binding to DNA was associated with motifs for 40 
CEBPB, GR and PPARA, but CREB1 showed no occupancy changes upon fasting (5). It has 
been known for several decades that cooperation of hormone-related transcription factor plays 
a role in the metabolic response to fasting (6). For instance, CREB1 and GR binding sites are 
often closely located on the same element and it has been shown that co-binding of the two 
factors is facilitated by Foxa2 (7).  45 
Despite an ever-increasing understanding of where in the genome fasting-related 
transcription factors bind, the mechanism of how these transcription factors interplay 
dynamically to control functional metabolic responses has been poorly understood. 
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Who is faster during fasting? 
In a recent publication in Genome Research, Goldstrein et al. deciphered how fasting 50 
shapes chromatin and transcription factor binding reorganization in mouse liver. They showed 
that DNAse I hypersensitivity sites with increased chromatin accessibility also display 
enriched H3K27ac (a histone mark associated with enhancer activity) upon fasting. These 
DNAse I hypersensitivity sites seem to be enriched near activated genes during fasting, even 
if it is not clear if they are located in promoters or enhancers. They then inferred the footprint 55 
depth of putative transcription factor binding location, the flanking accessibility, and motif 
enrichment. Using this unbiased data, they identified the four main transcription factors 
known to be involved synergistically in the transcriptional response to fasting: GR, CREB1, 
CEBPB and PPARA.  
The authors discovered two modules that operate sequentially after metabolic 60 
stimulation, initiated either by hormonal treatment of plated mouse primary hepatocytes or by 
food deprivation in mouse liver. CREB1 and GR represent the first module acting early 
during fasting by activating gluconeogenesis. During prolonged fasting, the GR-PPARA 
module eventually supplants CREB1-GR by stimulating fatty acid oxidation/ketogenesis gene 
expression, as has been seen previously in erythroid progenitor cells (8). The model proposed 65 
by the authors is that GR and PPARA may cooperate through a “transcription factor cascade” 
where GR progressively induces PPARA activity later during fasting, although definitive 
proof of this hypothesis will demand deeper mechanistic analysis.   
The authors then dissected the molecular mechanisms involved in the synergistic 
cooperation between CREB1 and GR. First, the binding sites for both CREB1 and GR were 70 
mapped after both transcription factors were activated by simultaneous treatment of 
hepatocytes with glucagon (CREB1 activation) and corticosterone (GR activation). By 
comparing with single-activation conditions, the increased occupancy of a subset of CREB1-
bound sites was found to be directly dependent on GR upregulation.  
Using data from their previous study (4) they showed that corticosterone-increased 75 
CREB1 sites, as well as fasting-induced enhancers, are in an open conformation after GR 
activation in mouse liver. Altogether, these observations suggest an “assisted loading” model 
for transcription factors where GR helps in the opening of fasting-induced enhancers to 
promote CREB1 binding. The authors have previously shown such a model with C/EBPB 
increasing the chromatin accessibility at numerous GR binding sites in mouse liver (4). The 80 
last section of the article describes validating single-cell experiments that explored how 
CREB1 binds DNA with or without GR activation. 
 
 This study deciphered the global chromatin changes and the relationship between the 
key transcription factors involved in fasting in mouse liver, but the genomic and 85 
computational approaches have important limitations. For instance, DNase-seq footprinting 
works unevenly for different transcription factors. Validating DNAse-seq results using similar 
techniques such as ATAC-seq would be useful. Further, in silico identification of 
transcription factor binding sites is always imperfect, since even a perfect transcription factor 
matrix does not directly show transcription factor binding much less functional binding. By 90 
combining the chromatin accessibility and H3K27ac occupancy, the authors generated a vast 
catalogue of cis-regulatory elements that are assigned as enhancers. It is not clear how they 
differentiate enhancers and promoters, both of which carry H3K27ac and can correspond to 
DNAse I hypersensitivity sites.  
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 Interestingly, the results of Goldstein et al contradict a prior study on how fasting 95 
impacts CREB1 occupancy, where the authors found an enrichment of CREB1 binding at 
fasted-induced enhancers during fasting versus feeding in the liver, a result discordant with a 
previous study (5). Although the experimental stimulation of CREB1 by glucagon and 
corticosterone in cell lines may not perfectly reflect the binding enrichment of CREB1 when 
found in vivo, Goldstein et al have confirmed key features of their in vitro results in liver. 100 
Finally, the authors nicely showed that two transcription factor modules are governing 
two phases of the metabolic response to food deprivation. While transcription factor cascades 
seem to be widely documented models in hormonal responses, to our knowledge an assisted 
loading model has not been reported outside the liver field. This last model is reminiscent of 
pioneer transcription factors that increase chromatin accessibility for other transcription 105 
factors by binding to nucleosomes transiently or along with other non-pioneer transcription 
factors. 
In sum, this study shows how an integrated analysis using the tools of functional 
genomics, when cleverly applied, can dissect how regulatory networks orchestrate metabolic 
responses to fasting.  110 
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Figure legend: 
Two regulatory modules operate during fasting in the liver. 140 
The CREB1-GR and the GR-PPARA modules transcriptionally regulate the genes involved in 
gluconeogenesis and fatty acid oxidation/ketogenesis in the liver, respectively. Left panel: 
First, glugacon activates CREB1 by phosphorylation, and the binding of CREB1 to target 
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gene enhancers drives limited gluconeogenic gene expression; CEBPB constituitively binds 
gluconeogenic enhancers. Second, further secretion of corticosterone activates GR, which 145 
then facilitates the binding of CREB1 by assisted loading. The subsequent co-binding of 
CREB1 and GR leads to synergistically enhanced gluconeogenic gene expression. Right 
panel: Glucagon-activated GR can bind enhancers of the PPARA gene and drives its 
expression. Then, PPARA regulates downstream fatty acid oxidation/ketogenic gene 
expression by binding at fasting-induced enhancers. This successive activation of genes 150 
during late fasting follows a transcription factor cascade model. 
CEBPB: CCAAT enhancer binding-beta; CREB1: cAMP responsive element binding protein 
I; GR: glucocorticoid receptor; PPARA: peroxisome proliferator activated receptor alpha; 
FAO: Fatty Acid Oxidation. 

